Stem Cells In Drug Discovery – Progress and Challenges
Devyn Smith,
Head of Business Operations and Strategy, Medicinal Sciences Division,
Pfizer
Stem cells and related technology have been maturing, but when and how will these technologies enable drug discovery? What are some early opportunities for benefits?
|
|
